Vascular News and Research

RSS

Eating salmon benefits pregnant women and their babies

University of Granada researchers have proven that eating two servings of salmon reared at a fish farm (enriched with omega-3 fatty acids and only slightly contaminated) a week during pregnancy is beneficial both for the mother and child.

19 Mar 2012

Ampio completes partial planned interim review in Optina trial for diabetic macular edema

Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.

19 Mar 2012

Amphar, ETView Medical to distribute VivaSight airway devices

ETView Medical Ltd. announced today that it has entered into a distribution agreement with Amphar b.v. (Amphar). The agreement enables Amphar to market ETView's VivaSight platform, combining an airway ventilation tube with integrated continuous high resolution airway imaging for patient airway control and lung isolation capability in the Netherlands.

19 Mar 2012

Sanofi enters definitive agreement to acquire Pluromed

Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.

17 Mar 2012

Kensey Nash to resolve Angio-Seal license disputes with St. Jude Medical

Kensey Nash Corporation today announced that the Company has entered into a settlement agreement with St. Jude Medical which resolves all disputes between the two companies relating to the Angio-Seal vascular closure device licenses, as well as other related claims.

17 Mar 2012

PFO closure device no better than drugs alone in preventing recurrent strokes or TIAs

Loyola University Medical Center is one of the major enrollers in a landmark clinical trial that found that plugging a hole in the heart works no better than drugs in preventing strokes.

17 Mar 2012

Adalimumab may decrease vascular inflammation in patients with psoriasis

A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.

17 Mar 2012

Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis

VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.

17 Mar 2012

Older women with mild retinopathy more likely to have cognitive decline and related vascular changes

Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).

16 Mar 2012

Experts highlight latest advances in use of biomarkers in various diseases

Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.

16 Mar 2012

China Pharma revenue increases 9% to $81.2M for full year 2011

China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2011.

15 Mar 2012

Women with retinopathy more likely to have cognitive problems

People with mild vascular disease that causes damage to the retina in the eye are more likely to have problems with thinking and memory skills because they may also have vascular disease in the brain, according to a study published in the March 14, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

15 Mar 2012

Varicose veins may be a simple cosmetic issue or a serious medical problem

With spring break shorts and swimsuit season coming up, many people will soon show off their legs for the first time in months, and for some, that also means deciding what to do about unsightly varicose veins. The bulging purple or blue lines may be simply a cosmetic issue, or they could be a sign of a serious medical problem, says Mayo Clinic vascular surgeon Peter Gloviczki, M.D.

14 Mar 2012

Health Central installs RADREX-i digital radiographic X-ray system

Time is critical in emergency departments (EDs), and fast diagnoses improve treatment and patient care. To reduce exam times and increase throughput in its ED, Health Central in Ocoee, Fla., installed Toshiba America Medical Systems, Inc.'s RADREX-i digital radiographic (DR) X-ray system.

14 Mar 2012

Both low-carb and low-fat diets help improve blood vessel function in overweight people

Overweight people who shed pounds, especially belly fat, can improve the function of their blood vessels no matter whether they are on a low-carb or a low-fat diet, according to a study being presented by Johns Hopkins researchers at an American Heart Association scientific meeting in San Diego on March 13 that is focused on cardiovascular disease prevention.

14 Mar 2012

FTY720 improves locomotor recovery in mice with SCI

A new study suggests that administering FTY720, an oral drug that has shown promise in trials for human multiple sclerosis, significantly improves locomotor recovery in mice with spinal cord injury.

13 Mar 2012

Blood vessels that form within brain cancers predominantly not made up of cancer cells

Johns Hopkins scientists have published laboratory data refuting studies that suggest blood vessels that form within brain cancers are largely made up of cancer cells. The theory of cancer-based blood vessels calls into question the use and value of anticancer drugs that target these blood vessels, including bevacizumab (Avastin).

10 Mar 2012

Cancer-based blood vessel theory questioned

8 Mar 2012

New minimally invasive procedure can treat resistant hypertension

A radically different approach to treating high blood pressure - using a minimally invasive procedure- is being evaluated as part of a Pivotal Phase III 90-site national trial that includes The Carl H. and Edyth Lindner Center for Research and Education at The Christ Hospital.

8 Mar 2012

FDA approves Covidien's EverFlex Self-Expanding Peripheral Stent System

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the EverFlex Self-Expanding Peripheral Stent System for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery.

7 Mar 2012